Grant of Interim Extension of the Term of U.S. Patent No. 5,593,823; INTERCEPT® Blood System for Plasma, 2821-2822 [2014-00723]
Download as PDF
<![CDATA[
ehiers on DSK2VPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 11 / Thursday, January 16, 2014 / Notices
3. Discussion of Public Hearing Draft
Amendment 28—Red Snapper
Allocation Analysis
4. Report of the Ad Hoc Red Snapper
IFQ Advisory Panel
5. Discussion of Amendment 39—
Recreational Red Snapper Regional
Management
6. Discussion of Amendment 40
Options Paper—Sector Separation
7. Discussion on Final Action of
Framework Action to Rescind
Amendment 30B Permit Conditions
8. Discussion of Standing and Reef
Fish Scientific and Statistical
Committee Report
9. Discussion on Exempted Fishing
Permits Related to Reef Fish
—Recess—
Immediately following recess will be
the Informal Question & Answer Session
on Gulf of Mexico fishery management
issues.
Mackerel Management Committee,
Wednesday, February 5, 8:30 a.m. until
11 a.m.
1. Final Action on CMP Amendment
20B Boundaries and Transit Provisions
2. Discussion of Options Paper for
2014 Joint Framework Action to Modify
Spanish Mackerel ACL/ACT
3. Discussion of Purpose and Timing
of Scoping Document for CMP
Amendment 24—Reallocation of Gulf
King Mackerel and Atlantic Spanish
Mackerel
4. Discussion of Purpose and Timing
of Scoping Document for CMP
Amendment 26—Split Permits between
the Gulf and South Atlantic for Spanish
and King Mackerel
Gulf SEDAR Committee, Wednesday,
February 5, 2014, 11 a.m. until 12 noon
1. Update on SEDAR 33: Gulf of
Mexico Gag and Greater Amberjack
2. Update on SEDAR 38: Gulf of
Mexico and South Atlantic King
Mackerel
3. Update on SEDAR Steering
Committee
4. Review of SEDAR Schedule
Council Session Agenda, Wednesday,
February 5, 2014, 1:30 p.m. until 5:30
p.m.
1:30 p.m.–1:45 p.m.: Call to Order and
Introductions, Adoption of Agenda and
Approval of Minutes.
1:45 p.m.–4:30 p.m.: The Council will
receive public testimony on Final
Action—Mackerel Amendments 20B—
Boundaries and Transit Provisions and
on Final Action—Framework Action to
Rescind Amendment 30B Permit
Conditions. The Council will also hold
an open public comment period
regarding any other fishery issues or
concerns. People wishing to speak
before the Council should complete a
public comment card prior to the
comment period.
VerDate Mar<15>2010
14:55 Jan 15, 2014
Jkt 232001
4:30 p.m.–4:45 p.m.: The Council will
review and vote on Exempted Fishing
Permits (EFP), if any.
4:45 p.m.–5:15 p.m.: The Council will
receive a committee report from the
Outreach and Education Management
Committee.
5:15 p.m.–5:30 p.m.: The Council will
receive a committee report from the
Shrimp Management Committee.
Council Session Agenda, Thursday,
February 6, 2014, 8:30 a.m. until 4:30
p.m.
8:30 a.m.–11:30 a.m.: The Council
will receive a committee report from the
Reef Fish Management Committee.
1 p.m.–1:30 p.m.: The Council will
receive a committee report from the
Sustainable Fisheries/Ecosystem
Management Committee.
1:30 p.m.–2:30 p.m.: The Council will
receive a committee report from the
Mackerel Management Committee.
2:30 p.m.–3:30 p.m.: The Council will
receive a committee report from the
Administrative Policy Management
Committee.
3:30 p.m.–4 p.m.: The Council will
receive a committee report from the Gulf
SEDAR Management Committee.
4 p.m.–4:30 p.m.: The Council will
review Other Business items: Summary
of Electronic Monitoring meeting, MREP
Summary, and Discussion on the
Reauthorization of the MagnusonStevens Fishery Conservation and
Management Act.
Although non-emergency issues not
contained in this agenda may come
before this group for discussion, those
issues may not be the subject of formal
action during this meeting. Action will
be restricted to those issues specifically
identified in this notice and any issues
arising after publication of this notice
that require emergency action under
section 305(c) of the Magnuson-Stevens
Fishery Conservation and Management
Act, provided the public has been
notified of the Council’s intent to take
final action to address the emergency.
Special Accommodations
These meetings are physically
accessible to people with disabilities.
Requests for sign language
interpretation or other auxiliary aids
should be directed to Kathy Pereira at
the Council Office (see ADDRESSES), at
least 5 working days prior to the
meeting.
Note: The times and sequence specified in
this agenda are subject to change.
Authority: 16 U.S.C. 1801 et seq.
PO 00000
Frm 00009
Fmt 4703
Sfmt 4703
2821
Dated: January 13, 2014.
Tracey L. Thompson,
Acting Deputy Director, Office of Sustainable
Fisheries, National Marine Fisheries Service.
[FR Doc. 2014–00736 Filed 1–15–14; 8:45 am]
BILLING CODE 3510–22–P
DEPARTMENT OF COMMERCE
Patent and Trademark Office
[Docket No. PTO–P–2013–0063]
Grant of Interim Extension of the Term
of U.S. Patent No. 5,593,823;
INTERCEPT® Blood System for Plasma
United States Patent and
Trademark Office, Commerce.
ACTION: Notice of interim patent term
extension.
AGENCY:
The United States Patent and
Trademark Office has issued an order
granting interim extension under 35
U.S.C. 156(d)(5) for a one-year interim
extension of the term of U.S. Patent No.
5,593,823.
FOR FURTHER INFORMATION CONTACT:
Mary C. Till by telephone at (571) 272–
7755; by mail marked to her attention
and addressed to the Commissioner for
Patents, Mail Stop Hatch-Waxman PTE,
P.O. Box 1450, Alexandria, VA 22313–
1450; by fax marked to her attention at
(571) 273–7755; or by email to
Mary.Till@uspto.gov.
SUPPLEMENTARY INFORMATION: Section
156 of Title 35, United States Code,
generally provides that the term of a
patent may be extended for a period of
up to five years if the patent claims a
product, or a method of making or using
a product, that has been subject to
certain defined regulatory review, and
that the patent may be extended for
interim periods of up to one year if the
regulatory review is anticipated to
extend beyond the expiration date of the
patent.
On December 3, 2013, Cerus
Corporation, the patent owner of record,
timely filed an application under 35
U.S.C. 156(d)(5) for an interim extension
of the term of U.S. Patent No. 5,593,823.
The patent claims the medical device
INTERCEPT® Blood System for Plasma.
The application indicates that a
Premarket Approval Application (PMA)
was submitted to the Food and Drug
Administration (FDA) in four modules.
The PMA Shell number BM120078 was
assigned on December 5, 2012. The first
module was received by the FDA on
March 1, 2013, the second module was
received on June 3, 2013, by the FDA,
the third module was received by the
FDA on September 3, 2013, and the
fourth module was received by the FDA
SUMMARY:
E:\FR\FM\16JAN1.SGM
16JAN1
2822
Federal Register / Vol. 79, No. 11 / Thursday, January 16, 2014 / Notices
on November 29, 2013. The medical
device is currently undergoing
regulatory review before the FDA for
permission to market or use the product
commercially.
Review of the application indicates
that, except for permission to market or
use the product commercially, the
subject patent would be eligible for an
extension of the patent term under 35
U.S.C. 156, and that the patent should
be extended for one year as required by
35 U.S.C. 156(d)(5)(B). Because the
regulatory review period will continue
beyond the original expiration date of
the patent, January 14, 2014, interim
extension of the patent term under 35
U.S.C. 156(d)(5) is appropriate.
An interim extension under 35 U.S.C.
156(d)(5) of the term of U.S. Patent No.
5,593,823 is granted for a period of one
year from the original expiration date of
the patent.
Dated: January 10, 2014.
Andrew Hirshfeld,
Deputy Commissioner for Patent Examination
Policy, United States Patent and Trademark
Office.
[FR Doc. 2014–00723 Filed 1–15–14; 8:45 am]
BILLING CODE 3510–16–P
DEPARTMENT OF EDUCATION
[Docket No.: ED–2013–ICCD–0139]
Agency Information Collection
Activities; Submission to the Office of
Management and Budget for Review
and Approval; Comment Request;
Evaluation of a District Wide
Implementation of a Professional
Learning Community Initiative
Department of Education (ED),
Institute of Education Sciences/National
Center for Education Statistics (IES).
ACTION: Notice.
AGENCY:
In accordance with the
Paperwork Reduction Act of 1995 (44
U.S.C. chapter 3501 et seq.), ED is
proposing a new information collection.
DATES: Interested persons are invited to
submit comments on or before February
18, 2014.
ADDRESSES: Comments submitted in
response to this notice should be
submitted electronically through the
Federal eRulemaking Portal at https://
www.regulations.gov by selecting
Docket ID number ED–2013–ICCD–0139
or via postal mail, commercial delivery,
or hand delivery. Please note that
comments submitted by fax or email
and those submitted after the comment
period will not be accepted. Written
requests for information or comments
submitted by postal mail or delivery
ehiers on DSK2VPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
14:55 Jan 15, 2014
Jkt 232001
should be addressed to the Director of
the Information Collection Clearance
Division, U.S. Department of Education,
400 Maryland Avenue SW., LBJ,
Mailstop L–OM–2–2E319, Room 2E107,
Washington, DC 20202.
FOR FURTHER INFORMATION CONTACT: For
questions related to collection activities
or burden, please call Katrina Ingalls,
703–620–3655 or electronically mail
ICDocketMgr@ed.gov. Please do not
send comments here. We will ONLY
accept comments in this mailbox when
the regulations.gov site is not available
to the public for any reason.
SUPPLEMENTARY INFORMATION: The
Department of Education (ED), in
accordance with the Paperwork
Reduction Act of 1995 (PRA) (44 U.S.C.
3506(c)(2)(A)), provides the general
public and Federal agencies with an
opportunity to comment on proposed,
revised, and continuing collections of
information. This helps the Department
assess the impact of its information
collection requirements and minimize
the public’s reporting burden. It also
helps the public understand the
Department’s information collection
requirements and provide the requested
data in the desired format. ED is
soliciting comments on the proposed
information collection request (ICR) that
is described below. The Department of
Education is especially interested in
public comment addressing the
following issues: (1) Is this collection
necessary to the proper functions of the
Department; (2) will this information be
processed and used in a timely manner;
(3) is the estimate of burden accurate;
(4) how might the Department enhance
the quality, utility, and clarity of the
information to be collected; and (5) how
might the Department minimize the
burden of this collection on the
respondents, including through the use
of information technology. Please note
that written comments received in
response to this notice will be
considered public records.
Title of Collection: Evaluation of a
District Wide Implementation of a
Professional Learning Community
Initiative.
OMB Control Number: 1850–NEW.
Type of Review: A new information
collection.
Respondents/Affected Public:
Individuals or households.
Total Estimated Number of Annual
Responses: 403.
Total Estimated Number of Annual
Burden Hours: 214.
Abstract: This study aims to address
the need for systematic information
about district-wide implementation of
professional learning communities
PO 00000
Frm 00010
Fmt 4703
Sfmt 4703
(PLCs) as a critical element in
improving teacher quality and
instruction, thereby contributing to
increased student achievement. The
study will survey (online) a population
of teacher participants in school-based
PLCs and interview principals face to
face about the context and their
perceptions of the initiative, pre- and
post-implementation. Data collection
from teachers will focus on what the
PLCs do, how they operate, and to what
extent they produce the outcomes
expected of them as framed by six
conceptual attributes of PLCs and five
specific tasks. Data collection from
principals will focus on contextual
information about school culture and
conditions such as resources that
support implementation. Teachers and
principals will also provide their
reflections on the challenges of
implementing PLCs and their
suggestions for improvement. The
analysis will enable comparisons among
PLCs within and across schools. Study
findings are expected to inform both
theory and practice related to
implementation of professional learning
communities.
Dated: January 10, 2014.
Stephanie Valentine,
Acting Director, Information Collection
Clearance Division, Privacy, Information and
Records Management Services, Office of
Management.
[FR Doc. 2014–00685 Filed 1–15–14; 8:45 am]
BILLING CODE 4000–01–P
DEPARTMENT OF ENERGY
Agency Information Collection
Extension
U.S. Department of Energy.
Notice and Request for OMB
Review and Comment.
AGENCY:
ACTION:
The Department of Energy
(DOE) has submitted an information
collection request to the OMB for
extension under the provisions of the
Paperwork Reduction Act of 1995. The
information collection requests a threeyear extension of its Occupational
Radiation Protection Program, OMB
Control Number 1910–5105. This
information collection request covers
information necessary to permit DOE
and its contractors to provide
management control and oversight over
health and safety programs concerning
worker exposure to ionizing radiation.
The Estimated Number of Total
Responses in the previously published
request for comments, 34, is incorrect;
the correct Estimated Number of Total
Responses is 170.
SUMMARY:
E:\FR\FM\16JAN1.SGM
16JAN1
]]>Agencies
[Federal Register Volume 79, Number 11 (Thursday, January 16, 2014)]
[Notices]
[Pages 2821-2822]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-00723]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Patent and Trademark Office
[Docket No. PTO-P-2013-0063]
Grant of Interim Extension of the Term of U.S. Patent No.
5,593,823; INTERCEPT[supreg] Blood System for Plasma
AGENCY: United States Patent and Trademark Office, Commerce.
ACTION: Notice of interim patent term extension.
-----------------------------------------------------------------------
SUMMARY: The United States Patent and Trademark Office has issued an
order granting interim extension under 35 U.S.C. 156(d)(5) for a one-
year interim extension of the term of U.S. Patent No. 5,593,823.
FOR FURTHER INFORMATION CONTACT: Mary C. Till by telephone at (571)
272-7755; by mail marked to her attention and addressed to the
Commissioner for Patents, Mail Stop Hatch-Waxman PTE, P.O. Box 1450,
Alexandria, VA 22313-1450; by fax marked to her attention at (571) 273-
7755; or by email to Mary.Till@uspto.gov.
SUPPLEMENTARY INFORMATION: Section 156 of Title 35, United States Code,
generally provides that the term of a patent may be extended for a
period of up to five years if the patent claims a product, or a method
of making or using a product, that has been subject to certain defined
regulatory review, and that the patent may be extended for interim
periods of up to one year if the regulatory review is anticipated to
extend beyond the expiration date of the patent.
On December 3, 2013, Cerus Corporation, the patent owner of record,
timely filed an application under 35 U.S.C. 156(d)(5) for an interim
extension of the term of U.S. Patent No. 5,593,823. The patent claims
the medical device INTERCEPT[supreg] Blood System for Plasma. The
application indicates that a Premarket Approval Application (PMA) was
submitted to the Food and Drug Administration (FDA) in four modules.
The PMA Shell number BM120078 was assigned on December 5, 2012. The
first module was received by the FDA on March 1, 2013, the second
module was received on June 3, 2013, by the FDA, the third module was
received by the FDA on September 3, 2013, and the fourth module was
received by the FDA
[[Page 2822]]
on November 29, 2013. The medical device is currently undergoing
regulatory review before the FDA for permission to market or use the
product commercially.
Review of the application indicates that, except for permission to
market or use the product commercially, the subject patent would be
eligible for an extension of the patent term under 35 U.S.C. 156, and
that the patent should be extended for one year as required by 35
U.S.C. 156(d)(5)(B). Because the regulatory review period will continue
beyond the original expiration date of the patent, January 14, 2014,
interim extension of the patent term under 35 U.S.C. 156(d)(5) is
appropriate.
An interim extension under 35 U.S.C. 156(d)(5) of the term of U.S.
Patent No. 5,593,823 is granted for a period of one year from the
original expiration date of the patent.
Dated: January 10, 2014.
Andrew Hirshfeld,
Deputy Commissioner for Patent Examination Policy, United States Patent
and Trademark Office.
[FR Doc. 2014-00723 Filed 1-15-14; 8:45 am]
BILLING CODE 3510-16-P
